Biodexa Pharmaceuticals (BDRX)

AI Score

Unlock

1.57

0.15 (10.56%)

At close: Apr 24, 2025, 3:59 PM

1.56

-0.95%

After-hours: Apr 24, 2025, 05:06 PM EDT

Biodexa Pharmaceuticals Balance Sheet Statement

Financials in GBP. Fiscal year is January - December.

Fiscal Year	Q4 2024	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018	Q2 2018	Q4 2017	Q2 2017	Q4 2016	Q2 2016
Period Ending	Dec 31, 2024	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018	Jun 30, 2018	Dec 31, 2017	Jun 30, 2017	Dec 31, 2016	Jun 30, 2016
Cash & Equivalents	1.67M	5.05M	5.97M	5.23M	2.84M	6.42M	10.06M	4.2M	7.55M	4.33M	10.93M	8.98M	2.34M	4.12M	13.2M	6.18M	17.61M	7.23M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	n/a	n/a	n/a	-698K	-837K	-993K	-1.15M	-1.25M	-542K	-1.73M	2.63M	78K	469K	463K	465K	460K	448K	387K
Receivables	715K	1.92M	n/a	2.04M	329K	1.24M	33K	1.4M	95K	3.67M	22K	879K	89K	719K	2.23M	4.61M	1.43M	3.23M
Inventory	n/a	n/a	-704K	-1.13M	1.00	1.00	1.00	n/a	n/a	n/a	1.00	1.00	n/a	n/a	941K	913K	817K	787K
Other Current Assets	n/a	547K	n/a	n/a	n/a	1.02M	n/a	1.42M	n/a	n/a	2.64M	4.12M	3.05M	15.65M	1.58M	n/a	1.86M	n/a
Total Current Assets	8.81M	7.52M	7.03M	7.26M	4.69M	8.69M	11.76M	7.03M	9.28M	10.27M	13.74M	14.33M	5.62M	20.49M	18.58M	11.7M	22.3M	11.24M
Property-Plant & Equipment	324K	436K	571K	693K	831K	993K	1.15M	1.25M	542K	954K	2.15M	1.75M	1.98M	2.52M	2.53M	2.73M	2.77M	2.47M
Goodwill & Intangibles	5.65M	6.01M	2.94M	5K	6K	n/a	n/a	n/a	n/a	778K	12.38M	12.38M	12.37M	12.38M	27.65M	30.39M	31.17M	42.51M
Total Long-Term Assets	5.97M	6.44M	3.51M	698K	837K	993K	1.15M	1.25M	542K	1.73M	17.16M	14.21M	14.83M	15.37M	30.64M	33.58M	34.39M	45.37M
Total Assets	14.78M	13.97M	10.54M	7.96M	5.53M	9.68M	12.91M	8.28M	9.82M	12M	30.89M	28.54M	20.44M	35.85M	49.22M	45.28M	56.69M	56.6M
Account Payables	707K	1.69M	314K	1.75M	339K	1.28M	485K	2.04M	337K	2.79M	725K	2.52M	286K	3.44M	2.27M	6.65M	3.27M	5.79M
Deferred Revenue	1.47M	n/a	926K	n/a	197K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	1.00	n/a	n/a
Short-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	107K	3.19M	179K	711K	288K	524K	322K	557K	507K	360K
Other Current Liabilities	921K	1.62M	4.23M	364K	583K	198K	664K	1.67M	1.68M	1.15M	2.77M	165K	792K	2.35M	2.64M	44K	3.54M	1.76M
Total Current Liabilities	5.03M	3.48M	5.57M	2.28M	1.9M	1.65M	1.84M	3.84M	2.99M	7.34M	5.67M	3.4M	2.47M	6.32M	8.36M	7.25M	9.35M	7.91M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	4.76M	383K	714K	6.16M	6.16M	1.22M	1.57M	1.44M
Other Long-Term Liabilities	1.31M	1.55M	n/a	-294	n/a	n/a	n/a	n/a	50K	n/a	n/a	n/a	165K	n/a	n/a	n/a	n/a	6.52M
Total Long-Term Liabilities	1.42M	1.76M	295K	379.71K	463K	546K	620K	682K	110K	107K	5.67M	383K	1.05M	6.16M	6.18M	1.22M	1.62M	7.96M
Total Liabilities	6.46M	5.24M	5.86M	2.66M	2.36M	2.19M	2.46M	4.52M	3.1M	7.45M	11.34M	3.78M	3.52M	12.48M	14.55M	8.47M	10.96M	15.87M
Total Debt	727K	382K	464K	544K	624K	546K	620K	682K	167K	3.3M	5.85M	1.09M	1.17M	6.68M	6.51M	1.78M	2.13M	1.8M
Common Stock	6.69M	3.63M	1.19M	277.97K	1.11M	98K	98K	63K	63K	39K	23K	20K	3K	3K	3K	2K	2K	2K
Retained Earnings	-150.42M	-147.88M	-144.77M	-138.97M	-135.34M	-130.76M	-127.8M	-125.55M	-122.43M	-117.73M	-99.84M	-94.11M	-89.72M	-86.16M	-74.65M	-67.87M	-59.11M	-47.28M
Comprehensive Income	53M	61.74M	53M	53M	53M	54.72M	54.72M	54.72M	54.72M	54.36M	53.49M	53.64M	53.7M	56.59M	56.39M	57.47M	57.62M	56.37M
Shareholders Equity	8.32M	8.73M	4.68M	5.3M	3.16M	7.49M	10.45M	3.75M	6.72M	4.55M	19.56M	24.75M	16.92M	23.37M	34.68M	36.81M	45.72M	40.73M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a